PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.36−0.68 (-13.49%)
Close on Nov 13, 2026Market cap $301.97MP/E –Yield –
PepGen cash
Cash and short-term investments held at the end of each period.
PepGen's cash was $104.80M at Sep 30, 2026. For fiscal 2025 it was $148.50M, up 23.5% from the year before. The highest annual figure on record is $181.75M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.50M | +23.5% |
| FY2024 | Dec 31, 2024 | $120.20M | +8.9% |
| FY2023 | Dec 31, 2023 | $110.40M | -39.3% |
| FY2022 | Dec 31, 2022 | $181.75M | +36.8% |
| FY2021 | Dec 31, 2021 | $132.90M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $104.80M | -36.0% |
| Q2 FY2026 | Jun 30, 2026 | $117.20M | +56.9% |
| Q1 FY2026 | Mar 31, 2026 | $132.30M | +35.3% |
| Q4 FY2025 | Dec 31, 2025 | $148.50M | +23.5% |
| Q3 FY2025 | Sep 30, 2025 | $163.70M | +17.9% |
| Q2 FY2025 | Jun 30, 2025 | $74.70M | -53.7% |
| Q1 FY2025 | Mar 31, 2025 | $97.80M | -44.2% |
| Q4 FY2024 | Dec 31, 2024 | $120.20M | +8.9% |
| Q3 FY2024 | Sep 30, 2024 | $138.90M | +7.2% |
| Q2 FY2024 | Jun 30, 2024 | $161.30M | +9.7% |
| Q1 FY2024 | Mar 31, 2024 | $175.20M | +5.9% |
| Q4 FY2023 | Dec 31, 2023 | $110.40M | -39.3% |
| Q3 FY2023 | Sep 30, 2023 | $129.54M | -33.8% |
| Q2 FY2023 | Jun 30, 2023 | $147.03M | -32.8% |
| Q1 FY2023 | Mar 31, 2023 | $165.40M | +39.2% |
| Q4 FY2022 | Dec 31, 2022 | $181.75M | +36.8% |
| Q3 FY2022 | Sep 30, 2022 | $195.78M | +38.3% |
| Q2 FY2022 | Jun 30, 2022 | $218.82M | +1240.3% |
| Q1 FY2022 | Mar 31, 2022 | $118.85M | +1682.7% |
| Q4 FY2021 | Dec 31, 2021 | $132.90M | – |
| Q3 FY2021 | Sep 30, 2021 | $141.54M | – |
| Q2 FY2021 | Jun 30, 2021 | $16.33M | – |
| Q1 FY2021 | Mar 31, 2021 | $6.67M | – |
See a number that looks wrong?